
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [INCY] Incyte Corp.
Data updated 2025-May-22 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-22 Thursday
Open | $64.73 | High | $65.33 +0.93% |
---|---|---|---|
Close | $64.51 | Low | $64.05 -1.05% |
Volume | 1.56 Million 0.97x | Volatility | 2.00% |
Change |
$-0.27
-0.42%
|
Streak | ↓ 2 days -1.21% |
20d SMA | $61.68 +4.6% | 50d SMA | $60.82 +6.1% | 100d SMA | $66.24 -2.6% | 200d SMA | $67.33 -4.2% |
RSI | 62 | MACD | 0.57 | ADX | 20.5 | Stochastic Oscillator | 85.1 89.1 |
CCI | 125.2 | ATR | 1.91 | OBV | 125 Million | Chaikin A/D | 245 Million |
Market Cap | 12.5 B | PEG Ratio | 0.116 | Trailing P/E | 324 | Forward P/E | 11.1 |
Price/Sales (ttm) | 2.84 | Price/Book (mrq) | 3.42 | EV/Revenue (ttm) | 2.31 | EV/EBITDA (ttm) | 25 |
% Held by Insiders | 1.58% | % Held by Institutions | 100.21% | Shares Short | 8.06 M | Shares Short (prior month) | 7.77 M |
Short Ratio | 4.27 | Short % of Outstanding | 4.16% | Short % of Float | 4.31% | Shares Short Change (mom) | +3.7% |
Revenue/Share (ttm) | $22.13 | Profit Margin (ttm) | 0.48% | Operating Margin (ttm) | 20.60% | EBITDA (ttm) | 303 M |
Diluted EPS (ttm) | $0.20 | Current Ratio (mrq) | 3.74 | Return on Assets (ttm) | 2.04% | Return on Equity (ttm) | 0.47% |
Qtr Earnings Growth (yoy) | 6.70% | Qtr Revenue Growth (yoy) | 19.50% | Operating Cash Flow (ttm) | 496 M | Free Cash Flow (ttm) | 611 M |
Choose view type
Monthly Performance for Incyte Corp.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Incyte Corp. up to close of 2025-May-22 at $64.51
3-month Performance Benchmarks for Incyte Corp.:
Related to Incyte Corp.
Information for Incyte Corp.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-22 on Google
SEC Reports : Quarterly reports around 2025-May-22 on SEC Edgar
Compare Incyte Corp. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Incyte Corp.
Industry : Biotechnology industry performance which includes Incyte Corp.